E6511
乙二胺四乙酸 四钠盐 二水合物
BioReagent, suitable for cell culture, 98.5-102.0%
别名:
EDTA 四钠盐, 乙二胺四乙酸四钠盐 二水合物, 依地酸钙钠
登录 查看组织和合同定价。
选择尺寸
关于此项目
线性分子式:
(NaOOCCH2)2NCH2CH2N(CH2COONa)2 · 2H2O
化学文摘社编号:
分子量:
416.20
UNSPSC Code:
12352204
NACRES:
NA.75
PubChem Substance ID:
EC Number:
200-573-9
Beilstein/REAXYS Number:
3861753
MDL number:
产品名称
乙二胺四乙酸 四钠盐 二水合物, BioReagent, suitable for cell culture, 98.5-102.0%
InChI
1S/C10H16N2O8.4Na.2H2O/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20;;;;;;/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20);;;;;2*1H2/q;4*+1;;/p-4
InChI key
KSYNLCYTMRMCGG-UHFFFAOYSA-J
SMILES string
O.O.[Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O
product line
BioReagent
assay
98.5-102.0%
form
powder
technique(s)
cell culture | mammalian: suitable
solubility
H2O: 160 mg/mL
shipped in
ambient
storage temp.
room temp
Quality Level
正在寻找类似产品? 访问 产品对比指南
Application
乙二胺四乙酸四钠盐二水合物用作：
- 螯合剂，从月经血中分离人子宫内膜干细胞/基质细胞（hEnSCs）
- 螯合剂，分离动物细胞和睾丸细胞
- 螯合剂，培养神经干细胞
Biochem/physiol Actions
乙二胺四乙酸(EDTA)用于消除痕量重金属对酶的抑制作用，并抑制需要二价阳离子作为辅因子的酶。
General description
乙二胺四乙酸（EDTA）是金属离子螯合剂。是一种取代二胺，具有抗菌活性。脱色过程中，EDTA消除铁离子、铜离子和锰离子产生的不良影响。可阻止细胞分裂，叶绿素合成和藻类生物量产生。EDTA 是金属蛋白酶的抑制剂。具有抗凝剂的特性。
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Dam. 1 - STOT RE 2
target_organs
Respiratory Tract
存储类别
11 - Combustible Solids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
What is the best protocol to cryopreserve immature mouse testicular cell suspensions?
Onofre J, et al.
Reproductive Biomedicine Online, 37(1), 6-17 (2018)
Human Endometrial Stem Cell Isolation from Endometrium and Menstrual Blood
Tavakol S, et al.
Bio-protocol, 8(2) (2018)
Modulation of matrix metalloproteinase activity by EDTA prevents posterior capsular opacification
Hazra S, et al.
Molecular Vision, 18(6), 1701-1701 (2012)
Accurate Results in the Clinical Laboratory: A Guide to Error Detection and Correction (2013)
Gitte Lund et al.
International archives of allergy and immunology, 153(4), 323-334 (2010-06-19)
Allergen-specific immunotherapy (SIT) leads to reduced symptoms upon allergen exposure through as yet unresolved mechanisms. Desensitization of basophils to specific allergens during the updosing phase of injection immunotherapy may contribute to the clinical effect of SIT. Here we report a
相关内容
Product Information Sheet
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持